Bone Support

Share Price

  • Contact Us
Follow
  • US site
    • Global English Site
    • US site
    • Global Swedish Site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Pipeline
    • Corporate Social Responsibility
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT®|BONE VOID FILLER
    • CERAMENT®
    • CERAMENT BEAD TRAY
    • Purchasing Products
    • CERAMENT®|BONE VOID FILLER transition facts
  • Medical Professionals
    • TRAUMA: WHY USE CERAMENT®
    • BENIGN BONE TUMORS: WHY USE CERAMENT®
    • FORTIFY Clinical Trial
    • REVISION ARTHROPLASTY: WHY USE CERAMENT
    • FOOT AND ANKLE: WHY USE CERAMENT
  • Investors
    • Financials
    • Financial Reports
    • Presentations
    • The Share
    • Shareholders
    • Analyst Coverage
    • Calendar
    • Q&A
    • Corporate Governance
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Media
    • Press Releases
    • Publications and Research
    • Multimedia
    • Events
  • Contact Us
  • Global English Site
  • US site
  • Global Swedish Site

  • Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

  • BONESUPPORT moves to Mid Cap

  • Thank you for subscribing

  • BONESUPPORT™ Founder Lars Lidgren Receives the 2017 OREF Clinical Research Kappa Delta Award

  • Strong CERAMENT data published in Science Advances

  • CERAMENT®|BONE VOID FILLER transition facts

  • Simon Cartmell leaves BONESUPPORT’s Board of Directors

  • BONESUPPORT HOLDING AB (publ) – Interim Report Q3 2020 – invitation to conference call and webcast

  • Corporate Governance

  • Contact Us

1 2 3 … 21 »

©BONESUPPORT AB 2021. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy